Cargando…

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors

α1‐adrenoceptor antagonists are widely used for hypertension (eg, doxazosin) and benign prostatic hypertrophy (BPH, eg, tamsulosin). Some antidepressants and antipsychotics have been reported to have α1 affinity. This study examined 101 clinical drugs and laboratory compounds to build a comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proudman, Richard G. W., Pupo, Andre S., Baker, Jillian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327383/ https://www.ncbi.nlm.nih.gov/pubmed/32608144 http://dx.doi.org/10.1002/prp2.602

Ejemplares similares

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G.W., et al.
Publicado: (2022)

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2021)

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G. W., et al.
Publicado: (2022)

Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)

The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
por: Batty, Mallory, et al.
Publicado: (2016)

"Ejaculatory disorders and α(1)-adrenoceptor antagonists therapy: clinical and experimental researches"
por: Grasso, Marco, et al.
Publicado: (2006)

Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
por: Latvala, Laura, et al.
Publicado: (2022)

Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil?
por: Tanuma, Yasushi, et al.
Publicado: (2016)

Chemically Homogenous Compounds with Antagonistic Properties at All α(1)-Adrenoceptor Subtypes but not β(1)-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats
por: Pytka, Karolina, et al.
Publicado: (2016)

Effect of α1D-adrenoceptor blocker for the reduction of ureteral contractions
por: Hong, Seong Hwi, et al.
Publicado: (2023)

Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil
por: Tanuma, Yasushi, et al.
Publicado: (2021)

A Novel Structural Framework for α(1A/D)-Adrenoceptor Selective Antagonists Identified Using Subtype Selective Pharmacophores
por: Stoddart, Emily S., et al.
Publicado: (2011)

The cytotoxicity of the α1-adrenoceptor antagonist prazosin is linked to an endocytotic mechanism equivalent to transport-P
por: Fuchs, Robert, et al.
Publicado: (2015)

Crystal structures, absolute configurations and molecular docking studies of naftopidil enantiomers as α(1D)-adrenoceptor antagonists
por: Xu, Wei, et al.
Publicado: (2017)

Effects of α-Adrenoceptor Antagonists on ABCG2/BCRP-Mediated Resistance and Transport
por: Takara, Kohji, et al.
Publicado: (2012)

Regression of Intracranial Meningioma during Treatment with α(1)-Adrenoceptor Blocker
por: Hoegestoel, Einar August, et al.
Publicado: (2016)

The Characteristics and Distribution of α2D-, α2B- and α2C-Adrenoceptor Subtypes in Goats
por: Xu, Ming, et al.
Publicado: (2022)

Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction
por: Kim, Jae Heon, et al.
Publicado: (2011)

Differences in the Signaling Pathways of α(1A)- and α(1B)-Adrenoceptors Are Related to Different Endosomal Targeting
por: Segura, Vanessa, et al.
Publicado: (2013)

The muscarinic receptor antagonist propiverine exhibits α(1)-adrenoceptor antagonism in human prostate and porcine trigonum
por: Wuest, Melinda, et al.
Publicado: (2011)

Norepinephrine Drives Persistent Activity in Prefrontal Cortex via Synergistic α1 and α2 Adrenoceptors
por: Zhang, Zizhen, et al.
Publicado: (2013)

α-Adrenoceptor blockers and phaeochromocytoma surgery: outdated combination?( )
por: Gunnesson, Lisa, et al.
Publicado: (2022)

Norepinephrine modulates wakefulness via α1 adrenoceptors in paraventricular thalamic nucleus
por: Wang, Yan, et al.
Publicado: (2021)

Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism
por: Lim, Iris, et al.
Publicado: (2022)

Impact of Polymorphic Variants on the Molecular Pharmacology of the Two-Agonist Conformations of the Human β1-Adrenoceptor
por: Baker, Jillian G., et al.
Publicado: (2013)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

Altered β(1−3)-adrenoceptor influence on α(2)-adrenoceptor-mediated control of catecholamine release and vascular tension in hypertensive rats
por: Berg, Torill
Publicado: (2015)

The presence of β(2)-adrenoceptors sensitizes α(2A)-adrenoceptors to desensitization after chronic epinephrine treatment
por: Bawa-Khalfe, Tasneem, et al.
Publicado: (2007)

α (2)-Adrenoceptors: Challenges and Opportunities—Enlightenment from the Kidney
por: Pettinger, William A., et al.
Publicado: (2020)

Negative cooperativity across β(1)-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation
por: Gherbi, Karolina, et al.
Publicado: (2015)

Both α(1)- and α(2)-adrenoceptors in the Insular Cortex Are Involved in the Cardiovascular Responses to Acute Restraint Stress in Rats
por: Alves, Fernando H. F., et al.
Publicado: (2014)

The role of α(1)- and α(2)-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2017)

Search for new α1a-adrenoceptor-selective antagonist for treating lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Khurana, Naval, et al.
Publicado: (2007)

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives as α(1A)-Adrenoceptor Antagonists
por: Xu, Wei, et al.
Publicado: (2015)

Endothelium-Dependent NO-Mediated Vasodilation in Humans is Attenuated by Peripheral α(1)-Adrenoceptor Activation
por: Kamper, Adriaan M, et al.
Publicado: (2005)

Synthesis and Characterization of Carbon-11 Labeled Iloperidone for Imaging of α(1)-Adrenoceptor in Brain
por: Xu, Yulong, et al.
Publicado: (2020)

Cardiac and Vascular α(1)-Adrenoceptors in Congestive Heart Failure: A Systematic Review
por: Kaykı-Mutlu, Gizem, et al.
Publicado: (2020)

High Vascular Tone of Mouse Femoral Arteries In Vivo Is Determined by Sympathetic Nerve Activity Via α(1A)- and α(1D)-Adrenoceptor Subtypes
por: Zacharia, Joseph, et al.
Publicado: (2013)

Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction
por: Partin, J V, et al.
Publicado: (2003)

Acidosis reduces the function and expression of α(1D)-adrenoceptor in superior mesenteric artery of Capra hircus
por: Mohanty, Ipsita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pvs6tjhhr7spfccqeh89le0rvh